Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: Need for an antibiotic policy

BMC Infectious Diseases

Volumn 4, Issue , 2004, Pages

  Pinto Pereira, Lexley M ^a   Phillips, Marjorie ^b   Ramlal, Hema ^b   Teemul, Karen ^b   Prabhakar, P ^c  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b Port of Spain General Hospital   (Trinidad and Tobago)

^c Caribbean Epidemiology Centre   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; COST CONTROL; DATA ANALYSIS; DRUG COST; DRUG FORMULARY; DRUG MONITORING; DRUG UTILIZATION; FREQUENCY ANALYSIS; GENERAL HOSPITAL; GYNECOLOGY; HEALTH CARE POLICY; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL INFECTION; HOSPITAL LABORATORY; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; MEDICAL AUDIT; MEDICAL RECORD; MICROBIOLOGY; NONHUMAN; ORTHOPEDICS; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PUBLIC HEALTH SERVICE; STATISTICAL SIGNIFICANCE; SURGICAL WARD; TEACHING HOSPITAL; TRINIDAD AND TOBAGO; ADOLESCENT; ADULT; AGED; FEMALE; HOSPITAL; LEGAL ASPECT; MALE; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; POLICY; SPAIN; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FEMALE; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PUBLIC POLICY; SPAIN; TRINIDAD AND TOBAGO;

EID: 25444520301     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-4-59     Document Type: Article

References (28)

1. McGowen JE, Tenover FC: Control of antimicrobial resistance in the health- care system. Infect Dis Clin N Am 1997, 11:297-311.
2. Patterson JE, Antibiotic utilization: Is there an effect on antimicrobial resistance? Chest 2001, 119(Suppl 2):426-430.
3. Cosgrove SE, Kaye KS, Eliopoulous GM, Carmeli Y: Emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 2002, 162:186-190.
4. Sanders CC, Sanders WE: beta-lactam resistance in Gram negative bacteria: global trends and clinical impact. Clin Infect Dis 1992, 15:824-839.
5. Pfaller MA, Jones RN, Doern GV, Salazar JC: Multicenter evaluation of antimicrobial resistance to six broad spectum β-lactams in Colombia: Comparison of data from 1997 and 1998 using E test method. Diagn Microbiol Infect Dis 1999, 35:235-241.
6. Goossens H: MYSTIC (Meropenam Yearly Susceptibility Test Information Collection) results from Europe: comparison of antibiotic susceptibilities between countries and centre types. MYSTIC Study Group (European centres only). J Antimicrob Chemotherapy 2000, 46:39-52.
7. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M: Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998, 280:1233-1237.
8. Kim BN, Lee SO, Choi SH, Kim NJ, Woo JH, Ryu J, Kim YS: Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia an analysis f 249 cases caused by Citrobacter, Enterobacter and Serratia species. Int J Antimicrob Agents 2003, 22:106-111.
9. Rice LB, Eckstein EC, DeVente J, Shlaes DM: Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996, 23:118-124.
10. Dahms RA, Johnson EM, Statz CL, Lee JT, Dunn DL, Beilman GJ: Third-generation cephalosporins and vancomycin-resistant Enterococcus infection. Arch Surg 1998, 133:1343-1346.
11. Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO: Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003, 36:440-446.
12. Levett PN, Holt HA, McGowan AP: Resistance to third-generation cephalosporins in Barbados. West Indian Med J 1993, 42:69-71.
13. Nicholson AM, Gayle P, Roye-Green K: Extended spectrum betalactamase producing organisms at the University Hospital of the West Indies. West Indian Med J 2004, 53:104-108.
14. Cherian BP, Manjunath M, Pinto Pereira LM, Prabhakar P: Extended-spectrum beta-lactamase producing enterobacteriaceae in a tertiary care hospital in Trinidad and Tobago. West Indian Med J 2003, 52:31-33.
15. Minooee A, Rickman LS: Expanding the role of the infection control professional in the cost-effective use of antibiotics. Am J Infect Control 2000, 28:57-65.
16. Harvey K, Stewart R, Hemming M, Moulds R: Use of antibiotic agents in a large teaching hospital. Impact of antibiotic guidelines. Med J Aust 1983, 2:217-221.
17. Davis DA, Thompson MA, Oxyman AD, Haynes RB: Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995, 274:700-705.
18. Tiley SM, MacDonald JJ, Doherty PL, Ferguson JK, Fergusson JE: Active promotion of antibiotic guidelines: an intensive program. Commun Dis Intell 2003, 27(Suppl):13-8.
19. Robertson MB, Korman TM, Dartnell JG, Ioannides-Demos LL, Kirsa SW, Lord JA, Munafo L, Byrnes GB: Victorian Drug Usage Evaluation Group Ceftriaxone and cefotaxime use in Victorian Hospitals. Med J Aust 2002, 176:524-529.
20. LeMire M, Wing L, Gordan DL: An audit of third generation cephalosporin prescribing in a tertiary care hospital. Aust N Z J Med 1996, 26:386-390.
21. Kumarasamy Y, Cadwgan T, Gilanders IA, Jappy B, Laing R, Gould IM: Optimizing antibiotic therapy-the Aberdeen experience. Clin Microbiol Infect 2003, 9:406-411.
22. Gorecki P, Schein M, Rucinski JC, Wise L: Antibiotic administration in patients undergoing surgical procedures in a community teaching hospital: the chaos continues. World J Surg 1999, 23:429-432.
23. Du B, Long Y, Chen D, Liu D, Xu Y, Xie X: Extended-spectrum beta-lactamase-producing Escheria coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002, 28:1718-1723.
24. Hoopi PY, Yong CM, Cheong I: A study of the appropriateness of antibiotic use in the medical wards of a tertiary teaching hospital in Malaysia. Int J Clin Pract 2001, 55:272-274.
25. Till B, Williams L, Oliver SP, Pillans PI: A survey of inpatient antibiotic use in a teaching hospital. S Afr Med J 1991, 80:7-10.
26. Aswapokee N, Vaithayapichet S, Heller RF: Pattern of antibiotic use in medical wards of a university hosipital, Bangkok, Thailand. Rev Infect Dis 1990, 12:136-141.
27. World Health Organization: WHO global strategy for containment of antimicrobial resistance. 2001 http://www.who.int/emc-documents/antimicrobial_resistance/docs/ EGlobal_Strat.pdf
28. Du B, Chen D, Liu D, Long Y, Shi Y, Wang H, Rui X, Cui N: Restriction of third-generation cephalosporin use decreases infection-related mortality. Crit Care Med 2003, 31:1088-1093.